U.S. CDC to Review Chikungunya, Influenza, Pneumococcal, and RSV Vaccines Next Week

Next week, the U.S. CDC's Advisory Committee on Immunization Practices (ACIP) vaccine experts and staff will meet in Atlanta, Georgia, to review scientific data and vote on vaccine recommendations.

The agenda for the October 23-24, 2024, meeting includes presentations focused on chikungunya, influenza, pneumococcal, and RSV, but it is not limited to these diseases/vaccines.

Several ACIP votes are planned during the meeting. The vote language linked here is considered 'draft language.' 

All ACIP votes and recommendations are not final until the CDC's Director approves them.

Members of the public interested in making an oral public comment are strongly encouraged to submit a request to the CDC no later than October 18, 2024.